Stay updated on INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.

Latest updates to the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe NCT03544736 record presents details of a phase I/II study evaluating nivolumab alongside radiotherapy-based treatment for esophageal cancer, including study design, eligibility requirements, interventions, and outcome measures.SummaryDifference59%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH website updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe 403 Forbidden message and its Home link disappear, leaving the study record area blank.SummaryDifference0.5%

Stay in the know with updates to INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.